Cite
HARVARD Citation
Velasco, R. et al. (n.d.). P10.04 Incidence and characteristics of neurological adverse events secondary to immunotherapy with checkpoint inhibitors. Neuro-oncology. p. iii41. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Velasco, R. et al. (n.d.). P10.04 Incidence and characteristics of neurological adverse events secondary to immunotherapy with checkpoint inhibitors. Neuro-oncology. p. iii41. [Online].